Fig. 3From: Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1Kaplan-Meier curves for progression-free survival in the hormone receptor-negative subpopulation (investigator assessment). a Asian subset. b Non-Asian subsetBack to article page